Brokrage Reports
Nomura on Exide
Buy, TP Rs 223
CITI on Exide Ind
Buy, TP Raised to Rs 260
Investec on Exide
Buy, TP Rs 220
Equirus on Exide Ind
Downgrade to reduce, TP Rs 194 from Rs 248
UBS on Exide
Buy, TP Raised to Rs 240
CS on Steel
Stay cautious on steel price outlook in medium term
While Indian spreads have fallen, those in China & Europe have improved
Expect coking coal to revert to $160/t & ore may fall further to $100/t, reducing cost support even more
CLSA on M&M Fin
Buy, TP raised to Rs 210 from Rs 180
Citi on M&M finance maintain buy with Tgt price of 185
Nomura on hdfc life maintain neutral with Tgt price of 750
Jp Morgan on hdfc life maintain OW with Tgt price of 770
CS on hdfc life maintain neutral with Tgt price of 670
Clsa on hdfc life maintain OP with Tgt price of 790
Clsa on zeel maintain buy with Tgt price of 306
Nomura on Exide
Buy, TP Rs 223
CITI on Exide Ind
Buy, TP Raised to Rs 260
Investec on Exide
Buy, TP Rs 220
Equirus on Exide Ind
Downgrade to reduce, TP Rs 194 from Rs 248
UBS on Exide
Buy, TP Raised to Rs 240
CS on Steel
Stay cautious on steel price outlook in medium term
While Indian spreads have fallen, those in China & Europe have improved
Expect coking coal to revert to $160/t & ore may fall further to $100/t, reducing cost support even more
CLSA on M&M Fin
Buy, TP raised to Rs 210 from Rs 180
Citi on M&M finance maintain buy with Tgt price of 185
Nomura on hdfc life maintain neutral with Tgt price of 750
Jp Morgan on hdfc life maintain OW with Tgt price of 770
CS on hdfc life maintain neutral with Tgt price of 670
Clsa on hdfc life maintain OP with Tgt price of 790
Clsa on zeel maintain buy with Tgt price of 306
*Reliance Industries* has acquired Strand Life Sciences for a cash consideration of Rs 393 crore. A further investment of up to Rs 160 crore is expected to be completed by March 2023. the total investment will translate into 80.3% of equity share capital in Strand on a fully diluted basis.
Strand, which is a pioneer of genomic testing in India with bioinformatics software and clinical research solutions to healthcare providers including clinicians, hospitals, medical devices manufacturers, and pharmaceutical companies, posted a turnover was Rs 88.70 crore, and Net Profit of Rs 8.48 crore in FY 2021. Neutral
Strand, which is a pioneer of genomic testing in India with bioinformatics software and clinical research solutions to healthcare providers including clinicians, hospitals, medical devices manufacturers, and pharmaceutical companies, posted a turnover was Rs 88.70 crore, and Net Profit of Rs 8.48 crore in FY 2021. Neutral
*HealthCare Global (HCG)*, announced the acquisition of oncology hospital labs and clinical trials business from Strand Lifesciences as well as simultaneous divestment of its ~38.5% stake in Strand to Reliance Industries group company. HCG received consideration of ~Rs 157cr for sale of its ownership in Strand and acquired labs and clinical research business for a consideration of ~Rs 81cr with a set-off of ~Rs 7cr towards receivables. The transactions resulted in net cash inflow of ~Rs 83cr for HCG in addition to the take-over of the labs and clinical research business. *Positive*
Coking coal prices has further increased by $20 in last week. And up by $140 since April 2021. This will increased the cost by Rs.6200 where as HRC prices remain stable between April -Aug. Post correction in recent past Iron ore prices has come back to April level. Negative for steel companies
*Ashoka Buildcon* has received an EPC contract worth Rs. 1,567 Cr for upgrading a part of the NH-19 in West Bengal. (Total order book as on Q1FY22 was at Rs. 9472 Cr.) *Positive.*
*Dr Reddy* has entered into a definitive agreement with Citius Pharmaceuticals for the sale of its entire right of investigational anti- cancer agent E7777 (denileukin diftitox) and some related assets. The company would get $40 mn as upfront payment followed by milestone payment of $40 million related to approval of CTCL indication and up to $70 million for additional indication approvals. *Positive*
*CreditAccess Grameen:* Marginal improvement in collection trends.
_CreditAccess MFI:_ Collection Efficiency (excl arrears) improved to 92.5% in August from 91.0% in July. Maharashtra remains weak at 89%. PAR 0 stood at 15.9% in August v/s 21.9% in July while PAR 90 stood at 6.3% v/s 5.7% in July.
_Madura MFI:_ Collection Efficiency (excl arrears) improved to 86% in August from 83% in July. Maharashtra remains weak at 76%. PAR 0 stood at 19.5% in August v/s 18.7% in July while PAR 90 stood at 7.3% v/s 6.2% in July.
*Neutral*
_CreditAccess MFI:_ Collection Efficiency (excl arrears) improved to 92.5% in August from 91.0% in July. Maharashtra remains weak at 89%. PAR 0 stood at 15.9% in August v/s 21.9% in July while PAR 90 stood at 6.3% v/s 5.7% in July.
_Madura MFI:_ Collection Efficiency (excl arrears) improved to 86% in August from 83% in July. Maharashtra remains weak at 76%. PAR 0 stood at 19.5% in August v/s 18.7% in July while PAR 90 stood at 7.3% v/s 6.2% in July.
*Neutral*
Market Wizard
MARKET WIZARD NEWSLETTER ISSUE 26.pdf
MARKET WIZARD NEWSLETTER ISSUE 26 UPDATE
🎯Fundamental Stocks
▶️ D B Corp Ltd added at 90.8
▶️ Ion Exchange (India) Ltd added at 2330
▶️ JSW Ispat Special Products Ltd added at 33.7
▶️ RPP Infra Projects Ltd added at 74.8
🎯Technical Stocks
▶️ Orissa Minerals Ltd added at 2950
▶️ Salzer Electronics Ltd added at 163
▶️ S H Kelkar and Company Ltd added at 160.45
WE WILL ADD AT ALL MENTIONED SUPPORT LEVELS
TEAM MARKET WIZARD
🎯Fundamental Stocks
▶️ D B Corp Ltd added at 90.8
▶️ Ion Exchange (India) Ltd added at 2330
▶️ JSW Ispat Special Products Ltd added at 33.7
▶️ RPP Infra Projects Ltd added at 74.8
🎯Technical Stocks
▶️ Orissa Minerals Ltd added at 2950
▶️ Salzer Electronics Ltd added at 163
▶️ S H Kelkar and Company Ltd added at 160.45
WE WILL ADD AT ALL MENTIONED SUPPORT LEVELS
TEAM MARKET WIZARD
Mid Term Fundamental Bumper Pick
Buy Shiva Texyarn at CMP of 200 - 201 and dips till 190
Sl 185
Targets:- 207 - 210 - 214 - 219 - 225+
Above 225 we can see 235 - 255+
Disclaimer:- I am not SEBI Registered. Please consult your financial advisor before investing.
Nse - 804
Bse - 511108
Buy Shiva Texyarn at CMP of 200 - 201 and dips till 190
Sl 185
Targets:- 207 - 210 - 214 - 219 - 225+
Above 225 we can see 235 - 255+
Disclaimer:- I am not SEBI Registered. Please consult your financial advisor before investing.
Nse - 804
Bse - 511108